Prevalence of Androgen Receptor Expression in Triple Negative Breast Cancers According To BRCA1 Mutation Status

被引：0
|
作者：
Torous, Vanda Farahmand
Schnitt, Stuart
Garber, Judy
Hacker, Michele
Poles, Emily
Alexander, Brian
Lee, Larissa
Collins, Laura
Tung, Nadine
机构：
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
MODERN PATHOLOGY | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
164
引用
收藏
页码：44A / 44A
页数：1
相关论文
共 50 条
  • [41] Prevalence of BRCA1 and BRCA2 mutations in Jewish women with triple negative breast cancer
    Comen, E. A.
    Davids, M.
    Kirchhoff, T.
    Balistreri, L.
    Hansen, J.
    Kosarin, K.
    Offit, K.
    Robson, M. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [42] Androgen Receptor Expression In BRCA-Associated Breast Cancers
    Albarracin, Constance
    Trinidad, Celestine Marie
    Song, Juhee
    Ward, Kristin
    Dhamne, Sagar
    Rosen, Daniel
    Wu, Yun
    Chen, Hui
    Baghaki, Hayriye Sema
    Barrera, Angelica M. Gutierrez
    Arun, Banu
    LABORATORY INVESTIGATION, 2018, 98 : 44 - 44
  • [43] Androgen receptor expression is a favorable prognostic factor in triple-negative breast cancers
    Zuo, Tao
    Wilson, Parker
    Cicek, Ali Fuat
    Harigopal, Malini
    HUMAN PATHOLOGY, 2018, 80 : 239 - 245
  • [44] Androgen Receptor Expression In BRCA-Associated Breast Cancers
    Albarracin, Constance
    Trinidad, Celestine Marie
    Song, Juhee
    Ward, Kristin
    Dhamne, Sagar
    Rosen, Daniel
    Wu, Yun
    Chen, Hui
    Baghaki, Hayriye Sema
    Barrera, Angelica M. Gutierrez
    Arun, Banu
    MODERN PATHOLOGY, 2018, 31 : 44 - 44
  • [45] Differences in outcome of young breast cancer patients according to BRCA1 mutation status
    Gabrys, D.
    Trela, K.
    Boratyn-Nowicka, A.
    Suwinski, R.
    Grzybowska, E.
    Behrendt, K.
    Galwas-Kliber, K.
    Wojcieszek, R.
    Idasiak, A.
    Pekala, W.
    Pamula-Pilat, J.
    Budryk, M.
    Thames, H.
    BREAST, 2009, 18 : S72 - S73
  • [46] Differences in outcome of young breast cancer patients according to BRCA1 mutation status
    Gabrys, D.
    Behrendt, K.
    Grzybowska, E.
    Suwinski, R.
    Idasiak, A.
    Galwas, K.
    Wojcieszek, P.
    Pekala, W.
    Pamula-Pilat, J.
    Thames, H.
    EJC SUPPLEMENTS, 2008, 6 (07): : 184 - 184
  • [47] Differences in outcome of young breast cancer patients according to BRCA1 mutation status
    Gabrys, D.
    Trela, K.
    Boratyn-Nowicka, A.
    Suwinski, R.
    Grzybowska, E.
    Behrendt, K.
    Galwas, K.
    Wojcieszek, P.
    Idasiak, A.
    Thames, H.
    CANCER RESEARCH, 2009, 69 (02) : 119S - 119S
  • [48] Are estrogen receptor-positive breast cancers in BRCA1 mutation carriers sporadic?
    Sunil R Lakhani
    Kum Kum Khanna
    Georgia Chenevix-Trench
    Breast Cancer Research, 12
  • [49] Are estrogen receptor-positive breast cancers in BRCA1 mutation carriers sporadic?
    Lakhani, Sunil R.
    Khanna, Kum Kum
    Chenevix-Trench, Georgia
    BREAST CANCER RESEARCH, 2010, 12 (02)
  • [50] Characterization of estrogen receptor-positive breast cancers in BRCA1 mutation carriers
    Wang, Y.
    Collins, L.
    Schnitt, S.
    Garber, J.
    Tung, N.
    CANCER RESEARCH, 2009, 69 (02) : 137S - 137S
12345